Protagenic Therapeutics, Inc.\new Available-for-sale Securities
Protagenic Therapeutics, Inc.\new (PTIX) had Available-for-sale Securities of $0 as of 2019-03-31, per its 10-Q filed 2019-05-16.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecurities · last filed 2019-05-16
- 2019-03-31: Available-for-sale Securities $0.00.
- 2018-12-31: Available-for-sale Securities $250.39K.
- 2018-09-30: Available-for-sale Securities $493.83K.
- 2018-06-30: Available-for-sale Securities $849.57K.
| Period end | Available-for-sale Securities |
|---|---|
| 2019-03-31 | $0.00 10-Q · filed 2019-05-16 |
| 2018-12-31 | $250.39K 10-Q · filed 2019-05-16 |
| 2018-09-30 | $493.83K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $849.57K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $1.08M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $1.29M 10-K · filed 2019-03-29 |
| 2017-09-30 | $1.15M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $1.83M 10-Q · filed 2017-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |